What to do about the ADHD epidemic – William B. Carey, M.D.

What to do about the ADHD epidemic    William B. Carey, M.D. American Academy of Pediatrics Section on Developmental and Behavioral Pediatrics Newsletter, Autumn 2003, Pages 6-7 In the last two decades the United States has experienced a great increase in the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and…

Two-thirds foster care children in Mass on psych drugs_Globe /Psychiatry: Soviet Experience–American Fallacy

Two-thirds foster care children in Mass on psych drugs_Globe Psychiatry: Soviet Experience–American Fallacy Wed, 11 Aug 2004 The Boston Globe reports that 2/3 of children in state care in Massachusetts are being “treated” for mental illness with psychotropic drugs. Marie Parente, a legislator, and parents call for disclosure of “how…

Infomail Archive 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

| | |

Screening for Mental Illness: The Merger of Eugenics and the Drug Industry

Ethical Human Psychology and Psychiatry Volume 7, Number 2, Summer 2005 pp. 111-124 Screening for Mental Illness: The Merger of Eugenics and the Drug Industry Vera Hassner Sharav, MLS New York, NY The implementation by the President’s New Freedom Commission (NFC) to screen the entire United States population – children…

FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs

FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs Fri, 1 Jul 2005 Under public and congressional pressure to disclose fully the hazardous effects of widely prescribed drugs, the FDA is beginning to acknowledge the long-denied evidence: psychotropic drugs may INDUCE…

Drug safety Hearings-Sept-Congress/ FDA – Lilly Plans to Disclose Data

Drug safety Hearings-Sept-Congress/ FDA – Lilly Plans to Disclose Data Tue, 3 Aug 2004 A hearing about the possible connection between suicide and antidepressant drugs will be held on Aug 4, by the California Senate by Sen. Tom Torkalson, chairman of the Senate Task Force on Youth and Workplace Wellness…

European Medicines Agency finalises review of antidepressants in children / adolescents

European Medicines Agency finalises review of antidepressants in children / adolescents Tue, 26 Apr 2005 The European Medicines Agency (EMA) has issued a press release recommending warnings about the increased risk of suicide attempts and hostility for children and adolescents prescribed an SSRI or SNRI antidepressant –and added warnings about…

|

Protecting Human Subjects in Research: Are Current Safeguards Adequate?

Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on Public Health, Committee on Health, Education, Labor, &…

FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street

FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street Sun, 22 May 2005 “After 25 years and 35 studies, there is not a single straightforward experiment comparing typical unmedicated children with an ADHD diagnosis to typical controls.” But science is not what the…